TrialNature medicine2024

Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial.

Hongnan Mo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.